A Research on Formulation, Development and Investigation of Matrix Type Sustained Release Tablet of Antiulcer Drug by Using Soluble Polymer as a Drug Release Retarding Agent

Main Article Content

Satbir Singh Amit Kumar Kehar Singh

Abstract

Sustained release drug administration aims to treat the illness, reduce side effects, and improve patient compliance by altering the biopharmaceutical, pharmacokinetic, and pharmacodynamic aspects of the medication. The goal of the current study was to produce nizatidine (220 mg) sustained release tablets by utilizing a wet granulation method with various polymer concentrations, including chitosan, HPMC K100M, and Kollidon SR. Pre-formulation features, such as drug DSC analysis and FTIR studies, were investigated. We evaluated content homogeneity, thickness, hardness, friability, and weight uniformity, among other post-compression attributes. This study showed how the concentration of polymers affects the post-compression properties of the medication formulation.
Keywords: Sustained Release, chitosan, HPMC K100M, and Kollidon SR Drug Release, Nizatidine, Pre-formulation, characterization, post-compression parameters.

Article Details

How to Cite
Singh, S., Kumar, A., & Singh, K. (2024). A Research on Formulation, Development and Investigation of Matrix Type Sustained Release Tablet of Antiulcer Drug by Using Soluble Polymer as a Drug Release Retarding Agent. International Journal of Pharmaceutical and Biological Science Archive, 12(5), 16-24. Retrieved from https://ijpba.in/index.php/ijpba/article/view/530
Section
Articles